Latest filing published 27 Mar 2026 for 박셀바이오, €4,477.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -44.0%Entry ₩7,810 · Close 07 Oct 2026 ₩4,370
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
정성창: trading record in brief
정성창 is a declared insider of 박셀바이오 (senior executive), with filings sourced from DART (FSS). Between 26 April 2024 and 25 March 2026, the trades on record add up to 2 filings.
No open-market sale appears; the market trades are 2 purchases worth €16k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2026 alone, the filings show 1 purchase and no sales.
Most recently, on 27 March 2026, the filings show an open-market purchase worth €4,477 in 박셀바이오. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Companies and markets linked to 정성창
Open company profiles for insider transactions, fundamentals and analyst consensus when available.